Zhang, Qu
AstraZeneca (United States)
2 papers on CoChatORCID 0000-0001-5220-2665
Most cited papers
- Verified
Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
Zhang, Q., Luo, J., Wu, S., Si, H., Gao, C., Xu, W., Abdullah, S. E., Higgs, B. W., Dennis, P. A., van der Heijden, M. S., et al. (2020) · Cancer Discovery
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 348
- Verified
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
de Bono, J. S., Fleming, M. T., Wang, J. S., Cathomas, R., Miralles, M. S., Bothos, J., Hinrichs, M. J., Zhang, Q., He, P., Williams, M., et al. (2021) · Clinical Cancer Research
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 54
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free